Insider · CIK 0001784606

Carr Patricia

Reports to the SEC for 1 company · DUBLIN 4, L2

sec.gov

Transactions

Companies

Filings

CIK

0001784606

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-09	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,287 sh	$182.94	−$235K	6,512
2026-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Chief Accounting Officer	FTax Payment	−1,436 sh	$186.77	−$268K	7,799
2026-02-27	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,117 sh	$190.91	−$213K	9,235
2026-02-26	JAZZJazz Pharmaceuticals plcA Award	SVP, Chief Accounting Officer	AAward	+2,223 sh	—	—	11,605
2026-02-26	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,253 sh	$194.11	−$243K	10,352
2026-01-16	JAZZJazz Pharmaceuticals plcA Award	SVP, Chief Accounting Officer	AAward	+2,370 sh	—	—	9,382
2025-12-05	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−160 sh	$171.11	−$27.4K	7,012
2025-12-05	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+4,500 sh	$140.67	+$633K	11,512
2025-12-05	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−4,500 sh	$171.20	−$770K	7,012
2025-12-05	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−4,500 sh	—	—	0
2025-11-18	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−69 sh	$181.66	−$12.5K	7,012
2025-11-18	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+5,250 sh	$136.18	+$715K	12,262
2025-11-18	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−5,250 sh	$182.07	−$956K	7,012
2025-11-18	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−5,250 sh	—	—	0
2025-03-10	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,140 sh	$137.81	−$157K	7,012
2025-03-07	JAZZJazz Pharmaceuticals plcD Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−1,333 sh	$138.23	−$184K	8,152
2025-02-28	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−773 sh	$143.29	−$111K	9,485
2025-02-27	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+4,500 sh	$113.10	+$509K	12,737
2025-02-27	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−4,500 sh	$144.42	−$650K	8,237
2025-02-27	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+313 sh	$123.36	+$38.6K	8,550
2025-02-27	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−313 sh	$144.42	−$45.2K	8,237
2025-02-27	JAZZJazz Pharmaceuticals plcD Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−371 sh	$142.43	−$52.8K	7,866
2025-02-27	JAZZJazz Pharmaceuticals plcD Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−497 sh	$142.43	−$70.8K	7,369
2025-02-27	JAZZJazz Pharmaceuticals plcA Award	SVP, Chief Accounting Officer	AAward	+2,889 sh	—	—	10,258
2025-02-27	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−4,500 sh	—	—	0
2025-02-27	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−313 sh	—	—	0
2025-01-17	JAZZJazz Pharmaceuticals plcA Award	SVP, Chief Accounting Officer	AAward	+1,641 sh	—	—	8,237
2024-12-02	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−53 sh	$122.49	−$6,491.97	6,596
2024-06-07	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−163 sh	$108.83	−$17.7K	6,596
2024-03-07	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,768 sh	$116.98	−$207K	6,596
2024-03-06	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,236 sh	$120.85	−$149K	9,064
2024-03-06	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−700 sh	$117.51	−$82.3K	8,364
2024-03-01	JAZZJazz Pharmaceuticals plcA Award	SVP, Chief Accounting Officer	AAward	+2,987 sh	—	—	10,300
2024-01-17	JAZZJazz Pharmaceuticals plcA Award	SVP, Chief Accounting Officer	AAward	+1,327 sh	—	—	7,363
2023-12-04	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−50 sh	$121.39	−$6,069.735	5,986
2023-08-29	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−142 sh	$143.47	−$20.4K	5,986
2023-08-14	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−158 sh	$138.16	−$21.8K	6,128
2023-06-07	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−126 sh	$127.92	−$16.1K	6,286
2023-03-15	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,023 sh	$133.22	−$136K	6,286
2023-03-05	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−1,148 sh	$140.76	−$162K	7,309
2023-03-03	JAZZJazz Pharmaceuticals plcA Award	SVP, Chief Accounting Officer	AAward	+2,523 sh	—	—	8,457
2022-12-05	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−63 sh	$152.06	−$9,579.982	5,934
2022-08-15	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−142 sh	$156.86	−$22.3K	5,934
2022-08-15	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+2,000 sh	$113.10	+$226K	7,934
2022-08-15	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−2,000 sh	$160.29	−$321K	5,934
2022-08-15	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−2,000 sh	—	—	4,500
2022-08-08	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−158 sh	$152.33	−$24.1K	6,076
2022-06-02	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−131 sh	$150.26	−$19.7K	6,234
2022-05-11	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−722 sh	$147.51	−$107K	6,234
2022-05-10	JAZZJazz Pharmaceuticals plcS Sale	SVP, Chief Accounting Officer	SSale	−273 sh	$144.18	−$39.4K	6,956

Recent filings

Accepted (ET)
Mar 94
Carr Patricia0001784606-26-000012
SEC(opens sec.gov)
Mar 24
Carr Patricia0001784606-26-000007
SEC(opens sec.gov)
Jan 214
Carr Patricia0001784606-26-000002
SEC(opens sec.gov)
Dec 94
Carr Patricia0001784606-25-000007
SEC(opens sec.gov)
Nov 204
Carr Patricia0001784606-25-000004
SEC(opens sec.gov)
Mar 114
Carr Patricia0001765581-25-000031
SEC(opens sec.gov)
Mar 34
Carr Patricia0001765581-25-000010
SEC(opens sec.gov)

Companies

Jazz Pharmaceuticals plcSVP, Chief Accounting OfficerJAZZ

Address

5TH FL, WATERLOO EXCHANGE WATERLOO RD

DUBLIN 4, L2